Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy

Magnetic Resonance Imaging

Volumn 25, Issue 5, 2007, Pages 634-640

  Lymer, Katherine ^a   Haga, Kristin ^a   Marshall, Ian ^a   Sailasuta, Napapon ^b   Wardlaw, Joanna ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GE HEALTHCARE   (United States)

Author keywords

2D spectroscopy; GABA; J resolved; Reproducibility

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE;

APPARATUS; ARTICLE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGING SYSTEM; MEASUREMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; PRIORITY JOURNAL; REPRODUCIBILITY;

BRAIN CHEMISTRY; CHOLINE; CREATINE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 34249281667     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2006.10.010     Document Type: Article

References (36)

1. Taylor M., Bhagwagar Z., Cowen P.J., and Sharp T. GABA and mood disorders. Psychol Med 33 (2003) 387-393
2. Chang L., Cloak C.C., and Ernst T. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry 64 suppl 3 (2003) 7-14
3. Sanacora G., Mason G.F., and Krystal J.H. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 14 (2000) 23-45
4. 1H MRS. Arch Gen Psychiatry 58 (2001) 556-561
5. Petroff O.A., Pan J.W., and Rothman D.L. Magnetic resonance spectroscopic studies of neurotransmitters and energy metabolism in epilepsy. Epilepsia 43 (2002) 40-50
6. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., et al. Reduced cortical GABA levels in depressed patients determined by proton MRS. Arch Gen Psychiatry 56 (1999) 1043-1047
7. Terpstra M., Ugurbil K., and Gruetter R. Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magn Reson Med 47 (2002) 1009-1012
8. Epperson C.N., Haga K., Mason G.F., Sellers E., Gueorguieva R., Zhang W., et al. Cortical GABA levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59 (2002) 851-858
9. Hanstock C.C., Coupland N.J., and Allen P.S. GABA X2 multiplet measured pre- and post-administration of vigabatrin in human brain. Magn Reson Med 48 (2002) 617-623
10. Jensen J.E., Frederic B.D., Wang L., Brown J., and Renshaw P.F. Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in the human brain. Magn Reson Med 54 (2005) 783-788
11. Keltner J.R., Wald L.L., Christensen J.D., Maas L.C., Moore C.M., Cohen B.M., et al. A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses. Magn Reson Med 36 (1996) 458-461
12. 1H-NMR-spectroscopy. Brain Res Bull 55 (2001) 555-560
13. Weber O.M., Trabesinger A.H., Duc C.O., Meier D., and Boesiger P. Detection of hidden metabolites by localized proton magnetic resonance spectroscopy in vivo. Technol Health Care 5 (1997) 471-491
14. Weber O.M., Verhagen A., Duc C.O., Meier D., Leenders K.L., and Bosiger P. Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited MRS and PET. Magn Reson Imaging 17 3 (1999) 417-425
15. Keltner J.R., Wald L.L., Frederick B.D., and Renshaw P.F. In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn Reson Med 37 (1997) 366-371
16. McLean M.A., Simister R., Woermann F., Wald L., Williams S., and Duncan J. In vivo GABA measurement using a PRESS-localized double quantum filter in patients with malformations of cortical development and epilepsy (2001) 962 Glasgow, UK
17. McLean M.A., Busza A.L., Wald L.L., Simister R.J., Barke r., and Williams S.R. In vivo GABA+ measurement at 1.5T using a PRESS localized double quantum filter. Magn Reson Med 48 (2002) 233-241
18. Binesh N., Yue K., Fairbanks L., and Thomas M.A. Reproducibility of localized 2D correlated MR spectroscopy. Magn Reson Med 48 (2002) 942-948
19. Thomas M.A., Yue K., Binesh N., Davanzo P., Kumar A., Siegel B., et al. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 46 (2001) 58-67
20. 1H MR spectroscopy: strong coupling effects in vitro and in vivo. Magn Reson Imaging 13 (1995) 853-869
21. Hurd R.E., Gurr D., and Sailasuta N. Proton spectroscopy without water suppression: the oversampled J-resolved experiment. Magn Reson Med 40 (1998) 343-347
22. Ke Y., Cohen B.M., Bang J.Y., Yang M., and Renshaw P.F. Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res 1000 (2000) 169-178
23. Levy L.M., Ziemann U., Chen R., and Cohen L.G. Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol 52 (2002) 755-761
24. Levy L.M., and Hallett M. Impaired brain GABA in focal dystonia. Ann Neurol 51 (2002) 93-101
25. Hwang J.H., Levenson H., Sutherling W., Sailasuta N., Hurd R.E., and Ross B.D. Detection of elevated GABA signals in the human brain at 1.5Tesla using phase-sensitive 2D J-resolved H-1 spectroscopy (1999) 1564 Glasgow, UK
26. 1H measurements of GABA in human brain in vivo. Proc Natl Acad Sci 90 (1993) 5662-5666
27. Mescher M., Merkle H., Kirsch J., Garwood M., and Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11 (1998) 266-272
28. Govindaraju V., Young K., and Maudsley A.A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13 (2000) 129-153
29. Hetherington H.P., Newcomer B.R., and Pan J.W. Measurements of human cerebral GABA at 4.1T using numerically optimized editing pulses. Magn Reson Med 39 (1998) 6-10
30. Petroff O.A., Hyder F., Rothman D.L., and Mattson R.H. Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology 56 (2001) 709-715
31. 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 17 (1999) 291-299
32. 1H NMR spectra of human brain. Magn Reson Med 32 (1994) 294-302
33. 1H-MR spectra of alcohol-dependant and hepatic encephalopathy patients. Am J Psychiatry 156 (1999) 952-954
34. Jacobs M.A., Horska A., van Zijl P.C.M., and Barker P.B. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med 46 (2001) 699-705
35. Pijnappel W.W.F., van den Boogaart A., de Beer D., and van Ormondt R. SVD-based quantification of magnetic resonance signals. J Magn Reson 97 (1992) 122-134
36. 0 homogeneity variation with head pitch by registered three-dimensional field mapping. J Magn Reson 159 (2002) 213-218